Stay updated on Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedA new version entry (82) with a Study Status update was added to the history page, reflecting routine record-keeping. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 at the bottom of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedVersion 81 was added on 2025-11-07 reflecting an updated Study Status. A government funding lapse notice from 2025-10-10 was removed.SummaryDifference0.5%

- Check43 days agoChange DetectedNew history entries have been added to the Record History page, reflecting updated submission dates and ongoing record-keeping. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page now includes a new date entry and a note about study status/design, while an older date is removed; core content and critical details remain unchanged.SummaryDifference0.9%

- Check71 days agoChange DetectedUpdated the page to announce v3.2.0 with a funding-related operating status notice, replacing the previous v3.1.0. Key impact: users are informed about potential service disruptions and where to verify status.SummaryDifference8%

Stay in the know with updates to Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.